UNIVERSAL CANCER IMMUNOTHERAPY
Live / Applied — Non-final action mailed (as of 15 Mar 2026)
What this means for you
Not registered yet, but its 24 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99053458
- Mark type
- Stylized text
- Filed
- 24 Feb 2025
- Attorney of record
- ALICIA M. PASSERIN
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and cancer; Biological preparations for the treatment of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and cancer; Vaccines; Veterinary pharmaceutical preparations for the prevention of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and cancer; Veterinary pharmaceutical preparations for the treatment of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and cancer
Owner
- ImmunityBio, Inc., San Diego, CA, US
Prosecution history
- 15 Jun 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 15 Jun 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 15 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Mar 2026 — NON-FINAL ACTION E-MAILED
- 15 Mar 2026 — NON-FINAL ACTION WRITTEN
- 03 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Mar 2026 — ASSIGNED TO LIE
- 02 Mar 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 02 Mar 2026 — EX PARTE APPEAL-INSTITUTED
- 02 Mar 2026 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 02 Mar 2026 — EXPARTE APPEAL RECEIVED AT TTAB
- 28 Jan 2026 — ASSIGNED TO EXAMINER
- 01 Dec 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 01 Dec 2025 — FINAL REFUSAL E-MAILED